Paper15100722
Genetic mechanisms that underlie epilepsy.
Steinlein OK. Nat Rev Neurosci, 2004. Cited by 162 papers, by iCite.
Cite this record
ConductScience Library. Genetic mechanisms that underlie epilepsy. Papers, record 15100722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15100722
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epilepsy | Major topic |
| Animals | |
| Humans | |
| Ion Channels | |
| Mutation |
Source PubMed
Cited by84
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42268390 | Epilepsy-induced heart damage and sudep risk: ion channelopathies, calcium homeostasis, and the therapeutic potential of resveratrol. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42268390 | PubMed |
| 41585885 | Rodent models of genetic epilepsy and its association with neurocognitive impairment- a systematic review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41585885 | PubMed |
| 40601686 | Structural insights into heterohexameric assembly of epilepsy-related ligand-receptor complex LGI1-ADAM22. | Elife | 2025 | https://conductscience.org/library/papers/40601686 | PubMed |
| 40217485 | Therapeutic efficacy of voltage-gated sodium channel inhibitors in epilepsy. | Acta Epileptol | 2023 | https://conductscience.org/library/papers/40217485 | PubMed |
| 39349563 | Repositioning pinacidil and its anticonvulsant and anxiolytic properties in murine models. | Sci Rep | 2024 | https://conductscience.org/library/papers/39349563 | PubMed |
| 37305674 | The long-term neurodevelopmental outcomes of febrile seizures and underlying mechanisms. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37305674 | PubMed |
| 35528035 | Invertebrate neurons as a simple model to study the hyperexcitable state of epileptic disorders in single cells, monosynaptic connections, and polysynaptic circuits. | Biophys Rev | 2022 | https://conductscience.org/library/papers/35528035 | PubMed |
| 34868252 | Transcriptome Analysis Reveals Higher Levels of Mobile Element-Associated Abnormal Gene Transcripts in Temporal Lobe Epilepsy Patients. | Front Genet | 2021 | https://conductscience.org/library/papers/34868252 | PubMed |
| 34766239 | Ameliorating Effect of Umbilical Cord Mesenchymal Stem Cells in a Human Induced Pluripotent Stem Cell Model of Dravet Syndrome. | Mol Neurobiol | 2022 | https://conductscience.org/library/papers/34766239 | PubMed |
| 34305610 | The Association Between STX1B Polymorphisms and Treatment Response in Patients With Epilepsy. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34305610 | PubMed |
| 33657187 | Sleep-related hypermotor epilepsy associated mutations uncover important kinetic roles of α4β2- nicotinic acetylcholine receptor intracellular structures. | PLoS One | 2021 | https://conductscience.org/library/papers/33657187 | PubMed |
| 33397806 | LGI1-ADAM22-MAGUK configures transsynaptic nanoalignment for synaptic transmission and epilepsy prevention. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/33397806 | PubMed |
| 33390815 | Great Expectations: Induced pluripotent stem cell technologies in neurodevelopmental impairments. | Int J Med Sci | 2021 | https://conductscience.org/library/papers/33390815 | PubMed |
| 33096746 | Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33096746 | PubMed |
| 33014431 | ALG13 participates in epileptogenesis via regulation of GABAA receptors in mouse models. | Cell Death Discov | 2020 | https://conductscience.org/library/papers/33014431 | PubMed |
| 32933463 | Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies. | Curr Neuropharmacol | 2021 | https://conductscience.org/library/papers/32933463 | PubMed |
| 32526953 | Investigating Cardiac Morphological Alterations in a Pentylenetetrazol-Kindling Model of Epilepsy. | Diagnostics (Basel) | 2020 | https://conductscience.org/library/papers/32526953 | PubMed |
| 32351181 | Antiepileptogenic Effect of Retinoic Acid. | Curr Neuropharmacol | 2021 | https://conductscience.org/library/papers/32351181 | PubMed |
| 31432233 | Insights into the mechanisms of epilepsy from structural biology of LGI1-ADAM22. | Cell Mol Life Sci | 2020 | https://conductscience.org/library/papers/31432233 | PubMed |
| 31396147 | Ictal Epileptic Headache: When Terminology Is Not a Moot Question. | Front Neurol | 2019 | https://conductscience.org/library/papers/31396147 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15100722
GET https://conductscience.org/api/papers/v1/15100722/cited_by?page=2